Towercrest Capital Management Johnson & Johnson Transaction History

Towercrest Capital Management

$630 Million
Q3 2024

A detailed history of Towercrest Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Towercrest Capital Management holds 6,721 shares of JNJ stock, worth $1.04 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,721

Previous 6,730 0.13%

Holding current value

$1.04 Million

Previous $983,000 10.78%

% of portfolio

0.17%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $1,309 - $1,506	-9 Reduced 0.13%	6,721 $1.09 Million
Q2 2024 Aug 06, 2024	SELL	$144.38 - $157.78 $1,155 - $1,262	-8 Reduced 0.12%	6,730 $983,000
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $64,416 - $67,537	415 Added 6.56%	6,738 $1.07 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $44,699 - $48,776	-307 Reduced 4.63%	6,323 $991,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $7,476 - $8,375	-48 Reduced 0.72%	6,630 $1.03 Million
Q2 2023 Aug 04, 2023	BUY	$154.35 - $166.11 $27,937 - $30,065	181 Added 2.79%	6,678 $1.11 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $21,298 - $25,416	141 Added 2.22%	6,497 $1.01 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $49,501 - $55,555	309 Added 5.11%	6,356 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $161 - $179	1 Added 0.02%	6,047 $988,000
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $9,013 - $10,236	-57 Reduced 0.93%	6,046 $1.07 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $10,915 - $12,110	-70 Reduced 1.13%	6,103 $1.04 Million
Q3 2021 Dec 10, 2021	SELL	$161.5 - $179.47 $5,491 - $6,101	-34 Reduced 0.55%	6,173 $997,000
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $2,392 - $2,566	-15 Reduced 0.24%	6,207 $1.02 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $22,348 - $24,890	-146 Reduced 2.29%	6,222 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $167,411 - $192,160	1,221 Added 23.72%	6,368 $1 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $9,265 - $10,152	66 Added 1.3%	5,147 $766,000
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $128 - $155	1 Added 0.02%	5,081 $715,000
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $49,457 - $68,525	-445 Reduced 8.05%	5,080 $666,000
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1,530 - $1,757	-12 Reduced 0.22%	5,525 $806,000
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $20,565 - $23,026	-162 Reduced 2.84%	5,537 $716,000
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $26,754 - $29,424	204 Added 3.71%	5,699 $793,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $21,246 - $23,624	169 Added 3.17%	5,495 $768,000
Q4 2018 Feb 15, 2019	BUY	$122.84 - $147.84 $1,474 - $1,774	12 Added 0.23%	5,326 $687,000
Q3 2018 Nov 19, 2018	BUY	$121.58 - $142.88 $13,495 - $15,859	111 Added 2.13%	5,314 $734,000
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $621,238 - $685,547	5,203 New	5,203 $631,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Towercrest Capital Management with notifications on news.

Account

Towercrest Capital Management Johnson & Johnson Transaction History